BIO-Europe took place last week in Stockholm. It’s one of the last big biopharma events of the year and a great time to take stock of where the industry stands...
The journey from Phase III clinical trials to a successful product launch is both exciting and challenging. It’s a crucial stage that sets the foundation for how a new product...
If you work with Evaluate, you’ll probably be familiar with our delightful Customer Success team. They’re the people who help ensure that our customers can use our solutions to navigate...
When a biotech or biopharma’s flagship asset is ready for out-licensing, which strategies will get it noticed by the right partners? To gain the attention of larger players, companies need...
For pharma companies, biotech assets present significant opportunities to strengthen pipelines with reduced risk. However, with such a vast ecosystem, identifying the right assets that align with your strategy can...
In the ever-evolving landscape of biopharma and biotech, competitive intelligence (CI) plays a crucial role in driving strategic decisions and maintaining a competitive edge. At the recent Pharma CI conference...